119 related articles for article (PubMed ID: 30700439)
1. Alpha-Blockers As Colorectal Cancer Chemopreventive: Findings from a Case-Control Study, Human Cell Cultures, and
Suzuki N; Niikura R; Ihara S; Hikiba Y; Kinoshita H; Higashishima N; Hayakawa Y; Yamada A; Hirata Y; Nakata R; Okamoto M; Sano M; Kushiyama A; Ichinose M; Woods SL; Worthley D; Iwamoto Y; Koike K
Cancer Prev Res (Phila); 2019 Mar; 12(3):185-194. PubMed ID: 30700439
[TBL] [Abstract][Full Text] [Related]
2. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
Tian Y; Xu Q; Sun L; Ye Y; Ji G
J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
[TBL] [Abstract][Full Text] [Related]
3. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
Huls G; Koornstra JJ; Kleibeuker JH
Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colorectal cancer.
Das D; Arber N; Jankowski JA
Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
Schrör K
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
[TBL] [Abstract][Full Text] [Related]
7. The Combination of Curcumin and Salsalate is Superior to Either Agent Alone in Suppressing Pro-Cancerous Molecular Pathways and Colorectal Tumorigenesis in Obese Mice.
Wu X; Koh GY; Huang Y; Crott JW; Bronson RT; Mason JB
Mol Nutr Food Res; 2019 Apr; 63(8):e1801097. PubMed ID: 30680927
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Subramanian V; Logan RF
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice.
Giner E; Recio MC; Ríos JL; Cerdá-Nicolás JM; Giner RM
Mol Nutr Food Res; 2016 Feb; 60(2):242-55. PubMed ID: 26502315
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive Effect of Aster glehni on Inflammation-Induced Colorectal Carcinogenesis in Mice.
Chung KS; Cheon SY; Roh SS; Lee M; An HJ
Nutrients; 2018 Feb; 10(2):. PubMed ID: 29439531
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
12. Aspirin as a chemoprevention agent for colorectal cancer.
Lee CS; McNamara D; O'Morain CA
Curr Drug Metab; 2012 Nov; 13(9):1313-22. PubMed ID: 22493984
[TBL] [Abstract][Full Text] [Related]
13. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
14. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF
Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160
[TBL] [Abstract][Full Text] [Related]
15. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
Pereira MA
Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of apoptosis indexes in currently used oral alpha-blockers in prostate: a pilot study.
Demir M; Akin Y; Terim KAK; Gulum M; Buyukfirat E; Ciftci H; Yeni E
Int Braz J Urol; 2018; 44(3):600-607. PubMed ID: 29617082
[TBL] [Abstract][Full Text] [Related]
17. Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin.
Zhu Y; Yang C; Weng M; Zhang Y; Yang C; Jin Y; Yang W; He Y; Wu Y; Zhang Y; Wang G; RajkumarEzakiel Redpath RJ; Zhang L; Jin X; Liu Y; Sun Y; Ning N; Qiao Y; Zhang F; Li Z; Wang T; Zhang Y; Li X
Oncotarget; 2017 Apr; 8(14):22759-22771. PubMed ID: 28184026
[TBL] [Abstract][Full Text] [Related]
18. Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas.
Fernando MA; Heaney AP
Mol Endocrinol; 2005 Dec; 19(12):3085-96. PubMed ID: 16020484
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase inhibitors: drugs for cancer prevention.
Shiff SJ; Shivaprasad P; Santini DL
Curr Opin Pharmacol; 2003 Aug; 3(4):352-61. PubMed ID: 12901943
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
